selected scholarly activity
-
journal articles
- Smart connected insulin dose monitoring technologies versus standard of care: a Canadian cost–effectiveness analysis. Journal of Comparative Effectiveness Research. 13:e230124. 2024
- Cost-effectiveness of enzalutamide versus apalutamide versus androgen deprivation therapy alone for the treatment of metastatic castration-sensitive prostate cancer in Canada. Journal of Medical Economics. 25:583-590. 2022
- Medication use and its impact on high-cost health care users among older adults: protocol for the population-based matched cohort HiCOSTT study. CMAJ open. 9:E44-E52. 2021
- Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators. BMC Cancer. 20:795. 2020
- Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study. BMJ Open. 9:e028637-e028637. 2019
- Disease-specific Preference-based Measure of Glaucoma Health States: HUG-5 Psychometric Validation. Journal of Glaucoma. 28:593-600. 2019
- Unplanned index hospital admissions among new older high-cost health care users in Ontario: a population-based matched cohort study. CMAJ open. 7:E537-E545. 2019
- Regional variation in healthcare spending and mortality among senior high-cost healthcare users in Ontario, Canada: a retrospective matched cohort study. BMC Geriatrics. 18:262-262. 2018
- Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma. Journal of Glaucoma. 27:585-591. 2018
- Managing High‐Cost Healthcare Users: The International Search for Effective Evidence‐Supported Strategies. Journal of The American Geriatrics Society. 66:1002-1008. 2018
- Senior high-cost healthcare users’ resource utilization and outcomes: a protocol of a retrospective matched cohort study in Canada. BMJ Open. 7:e018488-e018488. 2017
- SENIOR HIGH COST HEALTHCARE USERS: HOW DO THEY DIFFER?. Innovation in Aging. 1:55-55. 2017
- Loss of health related quality of life following low-trauma fractures in the elderly. BMC Geriatrics. 16:84. 2016
- Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis. Clinical and Investigative Medicine. 39:48-48. 2016